Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock
03 Settembre 2024 - 9:00AM
Business Wire
Leveraging Medidata solutions will enable
the CRO to improve clinical trial experiences for patients and
sponsors
Medidata, a Dassault Systèmes brand and leading provider of
clinical trial solutions to the life sciences industry, today
announced a new project with Aixial Group, a contract research
organization (CRO), to streamline the execution of studies and
achieve database lock faster. Aixial Group will migrate clinical
data from one of its business units onto the Medidata Platform to
create a Single Source of Truth (SSOT) that enables study teams to
support patient data privacy, monitor throughout the study to keep
patients safe, and make better-informed decisions.
"Aixial Group offers our trial sponsors the reliability and
flexibility at scale they need to accelerate their clinical
research programs and deliver results fast,” said Jonas M�ller,
managing director, Aixial Group. “Consolidating clinical data onto
the Medidata Platform will power the experience and expertise of
our teams to deliver this superior service for our customers,”
concluded Tim Corbett-Clark, chief technology officer, Aixial
Group.
“This engagement enables Aixial Group to provide increased
consistency and control within their operations, helping them
further excel in the global clinical research market,” said Janet
Butler, executive vice president, head of global sales, Medidata.
“Medidata Rave EDC will enhance their support for studies of any
size, length, or complexity and translate their productivity into
more patients accessing better treatments sooner.”
About Medidata
Medidata is powering smarter treatments and healthier people
through digital solutions to support clinical trials. Celebrating
25 years of ground-breaking technological innovation across more
than 34,000 trials and 10 million patients, Medidata offers
industry-leading expertise, analytics-powered insights, and the
largest patient-level historical clinical trial data set in the
world. More than 1 million registered users across approximately
2,200 customers trust Medidata’s seamless, end-to-end platform to
improve patient experiences, accelerate clinical breakthroughs, and
bring therapies to market faster. A Dassault Systèmes brand
(Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered
in New York City and has been recognized as a Leader by Everest
Group and IDC. Discover more at www.medidata.com and follow us
@Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. We provide
business and people with collaborative virtual environments to
imagine sustainable innovations. By creating virtual twin
experiences of the real world with our 3DEXPERIENCE platform and
applications, our customers can redefine the creation, production
and life-cycle-management processes of their offer and thus have a
meaningful impact to make the world more sustainable. The beauty of
the Experience Economy is that it is a human-centered economy for
the benefit of all – consumers, patients and citizens. Dassault
Systèmes brings value to more than 350,000 customers of all sizes,
in all industries, in more than 150 countries. For more
information, visit www.3ds.com.
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS
logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA,
CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE,
SIMULIA and SOLIDWORKS are commercial trademarks or registered
trademarks of Dassault Systèmes, a European company (Societas
Europaea) incorporated under French law, and registered with the
Versailles trade and companies registry under number 322 306 440,
or its subsidiaries in the United States and/or other countries.
All other trademarks are owned by their respective owners. Use of
any Dassault Systèmes or its subsidiaries trademarks is subject to
their express written approval.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240903518594/en/
Medidata PR Medidata.PR@3ds.com Analyst Relations
Medidata.AR@3ds.com
Grafico Azioni Big Tree Cloud (NASDAQ:DSY)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Big Tree Cloud (NASDAQ:DSY)
Storico
Da Nov 2023 a Nov 2024